Drug Discovery Congress 2018

Theme: Novel Strategies and Technologies for Drug Discovery and Medicinal Chemistry

Drug Discovery Congress 2018

Renowned Speakers

Chi Hin Cho
Chinese University of Hong Kong
Hong Kong

Thomas E Adrian
UAE University
UAE

S M Sivakumar
Jazan University
Saudi Arabia

Jinsong Bian
National University of Singapore
Singapore

Jiancheng Hu
Duke-NUS Medical School
Singapore

Hajime Hirao
City University of Hong Kong
China

Tzong Rong Ger
Chung Yuan Christian University
Taiwan

Suparerk Borwornpinyo
Mahidol University
Thailand

Gurleen Kour
Indian Institute of Integrative Medicine
India

Salvatore Cuzzocrea
University of Messina
Italy

Shai Rahimipour
Bar-Ilan University
Israel

Leila Motiei
Weizmann Institute of Science
Israel

Fatmanur TuÄŸcu-DemirÃ¶z
Gazi University
Turkey

Qiang Zhou
Peking University
China

Chang-Guo Zhan
University of Kentucky
USA

Gozde Unsoy
Middle East Technical University
Turkey

Seyed Ali Sadegh Zadeh
University of Hull School of Engineering and Science
UK

Mohammad Salhab
Chapel Allerton Hospital
UK

Fang Zheng
University of Kentucky
USA

It’s glad to organize “5th Annual Congress on Chemistry in Drug Discovery & Designing” (Drug Discovery Congress 2018) in UAE on April 16-17, 2018 at Dubai after a similar series of conferences in consecutive years at USA over the last several years which met with great achievement in Business Conferencing.

Working under the theme "Novel Strategies and Technologies for Drug Discovery and Medicinal Chemistry" this unique international conference will opportunity to reach the largest assemblage of participants from the Pharmaceutical community to gather and share their insights and convey recent developments in the field of generic drug research and current challenges and possibilities in modeling a new drug and breakthroughs in drug development, Generic drug safety, Novel trends and advanced strategies involving bioavailability bioequivalence research. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.

Drug Discovery Congress 2018 is a 2-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Target audience:

CEOs, CROs, Directors, Managers and research associates

Academic professionals

Industrial Scientists

Regulatory and Clinical Scientists

Researchers, Education providers

Students and Postdoctoral Fellows

Pharmacists

Government Agencies

Medical Practitioners

Clinical Pharmacologists

Clinical Toxicologists

Molecular and Cellular Pharmacologists

Why to attend??

Exchange ideas and network with leading pharmaceutical scientists and clinicians and presenting cutting-edge discoveries, research and new therapeutic drugs

Obtain a global roundup of Pharmaceutical research capabilities and opportunities

Track 1: Pharmaceutical Research & Development ( R&D)

In discovery process includes the primary phases of research, which are designed to categorize an investigational drug and perform primary tests in the lab. This first stage of the process takes approximately three to six years. By the end, researchers hope to identify a promising drug aspirant to further study in the lab and in animal models, and then in people.

These advances offer great promise, but also add complexity to the R&D process. In order to ensure the safety and efficacy of modified analyses that are used alongside diagnostics, clinical trial protocols must be modified and enhanced. This may need the use of additional procedures and resources, as well as new or innovative forms of data collection. Moreover, by their very nature, the patient population identified to respond to targeted therapies is narrower, which makes patient recruitment more difficult.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

9^th World Congress on Bioavailability & Bioequivalence, April 16-18, 2018 Dubai,UAE, International Conference on Biomarkers and Cancer Targets July 16-17, 2018 Dubai,UAE, International Conference on Medicinal and Pharmaceutical Chemistry,July 19-21, 2018 Dubai, UAE, 13^thWorld Congress on Healthcare and Medical Tourism, September 24-25, 2018 Dubai, UAE, World Conference on Pharmaceutical Chemistry and Drug Design, September 3-5, 2018 Dubai, UAE, 11^th Global Pharmacovigilance & Clinical Trials Summit, July 09-10, 2018 Sydney, Australia; 4^th Annual Drug Discovery Congress October 9-10, 2017, USA; Drug Discovery Chemistry, April 2-6, 2018 San Diego,USA; 19^th Annual Drug Discovery Summit, June 2018, Berlin, Germany; 6th Annual Discovery Chemistry & Drug Design Congress, June 2018, Berlin, Germany.12^th World Congress onPharmaceutical Sciences and Innovations in Pharma Industry, February 26- 27, 2018 London, UK, 2^nd International Conference and Exhibition on Pharmaceutical Development and Technology May 11-12, 2018 Tokyo, Japan, 17^th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic.

Related Associations or Societies:

Drug Information Association| Canadian Society for Pharmaceutical Sciences (CSPS)| Chemical Society Reviews| American Association of Pharmaceutical Scientists (AAPS)| Indonesian pharmaceutical association, Pharmaceutical Association of Malaysia (PhAMA), Malaysian Pharmaceutical Society,| International Society for Biological Therapy of Cancer| Pharmaceutical Group of the European Union (PGEU)The Pharmaceutical and Novel Drug Delivery Healthcare Sciences Society (PHSS)| Association of the British Pharmaceutical Industry (ABPI) | American Association of Pharmacy Technicians (AAPT)| American Associations of pharmaceutical scientists (AAPS)| The Pharmaceutical Research & Manufacturers Association (PhRMA)| Pharmaceutical Group of European Union (PGEU)| Alzheimer's Association Research (AAR)| Professional Compounding Centers of America| American Society of Health-System Pharmacists (ASHP)| American Society for Pharmacy Law American Society of Consultant Pharmacists (ASCP)

Track 2: Drug Discovery and Drug Development

Drug Design, usually specific to as rational drug design or just rational design, is that the creative method of finding new medications supported the data of a biological sciences target. The drug is most ordinarily associate degree organic little molecule that activates or inhibits the perform of a biomolecule like a macromolecule organic chemistry, that successively ends up in a therapeutic profit to the patient. Within the modest sense, drug design involves the planning of molecules that are opposite in form and charge to the bio molecular target with that they move and thus can bind to that. Drug design of times however not essentially depends on laptop modeling techniques. This sort of modeling is typically observed as computer-aided drug design. Finally, drug design that rely upon the data of the three-dimensional structure of the bio molecular target is thought as structure-based drug design. Additionally to little molecules, biopharmaceuticals and particularly therapeutic associate degree bodies are a more and more vital category of medicine and process strategies for rising the affinity, property, and stability of those protein-based drug delivery and medical specialty have conjointly been developed.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 3: Anti –Cancer Drug Discovery

Anticancer drug, also called antineoplastic drug, any drug that remains effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones. In addition, there are a number of drugs that do not fall within those classes but that demonstrate anticancer activity and therefore are used in the treatment of malignant disease. The term chemotherapy frequently is equated with the use of anticancer drugs, although it more accurately refers to the use of chemical compounds to treat disease generally. One of the major drugs that were used clinically in modern medicine for the treatment of cancer was the alkylating agent mechlorethamine, nitrogen mustard that in the 1940s was create to be effective in treating lymphomas. In 1956 the antimetabolite methotrexate became the first drug to cure a solid tumour.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 4: Drug Discovery of Rare Disease

Rare disease research has reached a listing point, with the confluence of scientific and technologic developments that if appropriately connected, could lead to key innovations and treatments for this set of devastating conditions. Industry-wide trends have discovered that the traditional drug discovery research and development (R&D) model is no longer viable, and drug companies are developing their approach. Rather than only pursue blockbuster therapeutics for heterogeneous, common diseases, drug companies have gradually begun to shift their focus to rare diseases. In academia, advances in genetics analyses and disease mechanisms have allowed scientific understanding to mature, but the shortage of funding and translational capability severely limits the rare disease research that leads to clinical trials.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 5: Perspective in Drug Discovery

It is driven by chemistry but gradually guided by pharmacology and the clinical sciences, drug research has contributed more to the development of medicine during the past century than any other scientific factor. Improving the science of drug development and directive is important in fulfilling the public health. The advent of molecular biology and, in particular, of genomic sciences is having a deep effect on drug discovery. Emphasis is placed on the contrast between the academic and industrial research operating environments, which can influence the efficacy of research collaboration between the two communities, but which plays such an important role in drug innovation. The strategic challenges that research directors face are also emphasized.

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical lending library of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as classical pharmacology.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 6: CADD (Computer Aided Drug Designing)

Drug Design through computer, a latest, very effective technique in modern arena. Now a days Computer Aided Drug Design (CADD) tools are cast-off in nanotechnology, molecular biology, biochemistry etc. The main benefit of the CADD is total effective in research and development of drugs. There are intensive people of code are employed in CADD, Grid computing, window generated general PBPK/PD modeling software, PKUDDS for structure based drug design, APIS, JAVA, Perl and Python, CADD as well as software including software libraries. There are different techniques used in CADD visualization, homology, molecular vibrant, energy minimization molecular docking, QSAR etc. Drug Design conference-2018 provides a stage to analytically analyze and understand the methods and mechanisms and Computer aided drug design is applicable in Cancer disease, conveyance of drug to specific site in body, data collections and storages of organics and biological.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 7: Hot Topics in Drug Targets

The term "biological target" is often used in pharmaceutical research to describe the natural protein in the body whose activity is modified by a drug resulting in a specific effect, which may be a desirable therapeutic effect or an unwanted adverse effect. In this context, the biological target is often referred to as a drug target. Target identification and validation are among the most important steps in developing a new drug. Drug target validation involves proving that either DNA, RNA, or a protein molecule is directly involved in a disease process and can be a suitable target for development of a new therapeutic drug Detecting the biological origin of a disease, and the potential objectives for intervention, is the first step in the discovery of a medicine. This has been a great challenge for both academia and industry. Targeted drug delivery systems have been developed to optimize regenerative techniques. The drug delivery system is highly incorporated and requires various disciplines, such as chemists, biologists, and engineers, to join forces to optimize this system.

There are dissimilar types of drug delivery sedans, such as polymeric micelles, liposomes, lipoprotein-based drug carriers, nano-particle drug carriers, dendrimers, etc. An ideal drug delivery vehicle must be non-toxic, biocompatible, non-immunogenic, biodegradable, and must avoid recognition by the host's defense mechanisms.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 8: In-silico Drug Design and in-silico screening

In modern periods, a growth towards the use of in-silico chemistry and molecular modelling for computer-aided drug design has gained significant momentum. In-silico drug design skills are used in nanotechnology, molecular biology, biochemistry, etc.

In-silico drug design can take part much in all stages of drug development from the preclinical discovery stage to late stage clinical development.

During the process of selection of novel drug candidates, many essential steps are taken to eliminate such compounds that have side effects and also show interaction with other drugs. In-silico drug designing softwares show an important role to design progressive proteins or drugs in biotechnology or the pharmaceutical field. The drug designing softwares and programs are used to examine molecular modelling of gene, gene expression, gene sequence analysis and 3D structure of proteins. In-silico methods have been of great importance in target identification and in forecast of novel drugs.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 9: Natural Products Drug Discovery

Modern natural product chemistry procedures assisted a vast array of bioactive secondary metabolites from terrestrial and marine sources to be discovered. Many of these natural products have gone on to become current drug candidates. An advance in technology and sensitive equipment for the rapid identification of novel bioactive natural products and structure elucidation continues to improve the natural product discovery process. Chemistry has indeed revolutionized the development of novel active chemical leads resulting in the synthesis of structural analogues. Natural products conventional a key source of pharmacologically active ingredients in a variety of novel agents with therapeutic potential in a wide range of diseases. Pharmaceuticals containing natural products or compounds derived from natural product scaffolds or templates have to undergo the same stringent approval process as drugs obtained from purely synthetic origin.

It is noteworthy that natural products are a source of new compounds with diversified structural arrangements possessing interesting biological activities. Natural products played and continue to play an invaluable role in the drug discovery process.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 10: Drug Discovery Using Nanotechnology

Nanotechnology contains the engineering of functional systems at the molecular scale which are characterized by unique physical, optical and electronic structures that are attractive for disciplines ranging from materials science to biomedicine. The use of nanotechnology in drug development is the emerging process where the nanoparticles used to deliver the drug to the specific cell which is diseased. By this technology the particles which are engineered in such a way that they can attract to the diseased cell and allows treatment to the particular cell directly. Through this unique technique can minimize the damage of healthy cells in the body.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 11: Structural Biology in Drug Discovery

Structural biology, the study of the structure of biological macromolecules, is suitable a physical advantage in the drug development process. Structural biology seeks to provide a complete and coherent picture of biological phenomena at the molecular and atomic level. The aims of structural biology consist of inconstant a complete understanding of the molecular shapes and forms embraced by biological macromolecules and extending this knowledge to understand how different molecular architectures are used to perform the chemical reactions that are central to life.

In addition, structural biologists are elaborate in understanding related processes such as protein folding, protein dynamics, molecular modeling, drug design, and computational biology. Central tools used in this research include X-ray diffraction, NMR, electron microscopy, other spectroscopies and biophysical methods, protein expression, bio-physical and bio-organic chemistry, computer science and bioengineering.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 12: Green Techniques for Medicinal Chemistry

Green Techniques for Organic Synthesis and healthful Chemistry awards a speedy of the established and rising techniques in inexperienced chemical science, light their applications in healthful chemistry. And it's a necessary resource on inexperienced chemistry technologies for tutorial researchers, R& D professionals and students operating in chemical science and healthful chemistry. In experienced chemistry is associate degree innovative manner of data at organic synthesis and therefore the style of drug molecules, role vital inexperienced and economic benefits over ancient artificial processes. Pharmaceutical corporations’ area unit bit by bit turning to the principles of inexperienced chemistry in an endeavor to cut back waste cut back prices and develop environmentally benign processes.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 13: Advance Trends in Organic Chemistry & Inorganic Chemistry

Organic reactions square measure chemical reactions involving organic compounds. The fundamental chemistry reaction sorts square measure addition reactions, elimination reactions, substitution reactions, pericyclic reactions, arranging reactions, chemistry reactions and reaction reactions. In organic synthesis, organic reactions square measure employed in the development of recent organic molecules. The assembly of the many synthetic chemicals like medicine, plastics, food additives, and materials depend upon organic reactions. There is no limit to the quantity of doable organic reactions and mechanisms. However, sure general patterns square measure determined that may be accustomed describe several common or helpful reactions. Every reaction features a stepwise reaction mechanism that explains however it happens, though this elaborate description of steps isn't invariably clear from a listing of reactants alone. Synthetic organic reactions will be organized into many basic sorts. Some reactions match into over one class. For instance, some substitution reactions follow an addition-elimination pathway.

In general the stepwise progression of reaction mechanisms will be diagrammatical victimization arrow pushing techniques during which incurved arrows square measure accustomed track the movement of electrons as starting materials transition to intermediates and products.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 14: Traditional Chinese Medicine Discovery

Traditional medicine originated and has evolved over thousands of years. Traditional Medicine is a system of primary health care that includes acupuncture, Chinese herbal medicine, remedial massage, exercise and breathing therapy and diet and lifestyle advice. In Australia, the most popular forms of TCM health care are acupuncture and Herbal Medicine. It has an uninterrupted history of development in China and other parts of East Asia dating back thousands of years.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 15: Process Chemistry and Drug Manufacturing

Process chemistry is the partition of pharmaceutical chemistry apprehensive with the development and optimization of a synthetic scheme and pilot plant procedure to manufacture compounds for the drug development phase. Process chemistry is distinguished from medicinal chemistry, which is the arm of pharmaceutical chemistry tasked with designing and synthesizing molecules on small scale in the early drug discovery phase Process chemistry cover organic chemistry, catalysis systems, analytical chemistry, process analytical technologies (PAT) and chemical/design engineering, laboratory process transfers to pilot and manufacturing with optimizations of chemical reactions which include research and process development in the pharmaceutical, fine chemicals, cosmetics, agrochemicals, dyestuffs and polymers.

Drug Manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be demolished into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 16: Women’s Health Drug Discovery & Therapy

Modern drug discovery comprises the drug development of steroidal and nonsteroidal drugs in numerous preclinical and clinical trials, with promising results in oncology and women’s health, including endometriosis, ovarian and endometrial cancer, breast cancer and conditions that affect elderly women, including frailty.

Research Priority Areas

1. Advance Safety and Efficacy: Advance safety and efficacy and decrease the toxicity of FDA-regulated products used by women

2. Improve Clinical Study Design and Analyses: Improve clinical study design and conduct to better identify and evaluate possible sex differences related to FDA-regulated products

3. Novel Modeling and Simulation Approaches: Evaluate and promote the adoption of novel modeling and simulation approaches that can aid in regulatory evaluation of FDA-regulated products

4. Advances in Biomarker Science: Develop tools and methods that can help identify, evaluate, and qualify predictive or prognostic clinical and non-clinical biomarkers and surrogate endpoints

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 17: Pharmacology and Toxicology in Drug Discovery

Pharmacology is that the division of drugs and biology involved with the study of drug action,, where a drug can be broadly described as any man-made, natural, or endogenous (from within body) molecule which exerts a biochemical and/or physiological issue on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More definitely, it is the study of the interactions that occur between a living organism and chemicals that alter normal or abnormal biochemical function. If substances have medicinal properties, they are contemplated pharmaceutical chemistry.

The field encompasses drug composition and properties, synthesis and drug style, molecular and cell mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and antipathogenic capabilities. The two main field of pharmacology are pharmacodynamics and pharmacokinetics.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 18: Drug Formulation/ Pharmaceutical formulation

Drug product formulation is at the fundamental of Particle Sciences. Industry-wide, distribution of active pharmaceutical ingredients (APIs) has taken center stage along with the API's themselves. Focused initially on problematic new chemical entities (NCEs), delivery systems are now the go-to approach for both NCE commercialization and the refinement and repurposing of existing APIs. The biological and chemical needs generally fall into one or a combination of a small number of categories. In addition to physicochemical and physiologic goals, business concerns also drive the use of sophisticated drug delivery systems.

Particle Sciences depend on formulation is a data compelled science and we follow a systematic efficient approach. After the client's needs are thoroughly understood and the target product profile (TPP) defined, a well-established product development algorithm begins. Starting with prescribed amount™, our convinced preformulation system and continuing through formulation, production for pre-clinical toxicology, scale up and clinical trial material production, Particle Sciences is expert at efficiently getting our clients to commercializable products.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 19: Proteomics & Bioinformatics

Proteomics, the large-scale analysis of proteins, contributes significantly to our understanding of gene function in the post-genomic era. Proteomics can be divided into three main areas: (1) protein micro-characterization for large-scale documentation of proteins and their post-translational changes; (2) differential display proteomics for comparison of protein levels with potential application in a extensive series of diseases; and (3) studies of protein–protein interactions using techniques such as mass spectrometry or the yeast two-hybrid system. Proteomics technologies are under continuous progresses and new technologies are introduced. Nowadays high quantity acquisition of proteome data is possible. The new and quickly rising field of bioinformatics in genetics is giving new algorithms to handle giant and heterogeneous knowledge sets and to enhance the data discovery method. Amide libraries supply a valuable suggests that for providing useful information relating to super molecule-modifying enzymes and protein interaction domains.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 20: Drug Discovery in Preclinical Research

In the drug development, presymptomatic development, additionally named presymptomatic studies and non-clinical studies, is a stage of investigation that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative difficult and drug safety data is collected. Preclinical; in the epidemiological triangle can also be defined as "pre-symptomatic stage" which is known to be, "not yet clinical obvious". The main goals of pre-clinical studies are to regulate the safe dosage for First-in-man study and start to assess product's safety profile. Products may include new or repeated or like-kind medical strategies, drugs, gene therapy solutions, etc. On average, only one in every 5,000 compounds that arrives drug discovery to the stage of pre-clinical development becomes an approved drug.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Track 21: Recent trends in Nutraceuticals Research

Nutraceuticals play an increasingly important role in the treatment of various chronic diseases such as colon cancer, diabetes and Alzheimer’s disease. Nutraceuticals are derived from various natural sources such as medicinal plants, marine organisms, vegetables and fruits.

Nutraceuticals may be used to improve health, delay the aging process, prevent chronic diseases, increase life expectancy, or support the structure or function of the body. Recent studies have shown promising results for these compounds in various pathological complications such as diabetes, atherosclerosis, cardiovascular diseases (CVDs), cancer, and neurological disorders. The recent innovations in Nutraceuticals field is said to be the future upsurge on the global public health issue. Nutricosmetics, new generation skin supplements for beauty and skin health. Nutrigenetics and Nutrigenomics, Food polymers in delivering dietary bio-actives and the Safety and Efficacy of emerging Nutraceuticals in global market.

Relevant Conferences: Drug Discovery Congress | Pharmaceutical events | Drug Discovery Conferences

Related Associations or Societies:

Drug Information Association| Chemical Society Reviews Indonesian pharmaceutical association, Pharmaceutical Association of Malaysia (PhAMA), Malaysian Pharmaceutical Society,| International Society for Biological Therapy of Cancer| The Pharmaceutical and Novel Drug Delivery Healthcare Sciences Society (PHSS)| American Associations of pharmaceutical scientists (AAPS)| The Pharmaceutical Research & Manufacturers Association (PhRMA)| Pharmaceutical Group of European Union (PGEU)| Alzheimer's Association Research (AAR).

Societies in USA: Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC), American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP). American Association of Pharmaceutical Scientists (AAPS)

Societies in Europe: Belgian Society of Pharmaceutical Sciences (BGFW), European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Association of the British Pharmaceutical Industry (ABPI). Pharmaceutical Group of the European Union (PGEU)

Societies in Asia and Pacific: The Pharmaceutical Society of Australia (PSA), Austrian Pharmaceutical Society (APS), Korean Research-based Pharmaceutical Industry Association (KRPIA), Kuwait Pharmaceutical Association (KPA), Korean Pharmaceutical Association (KPS), Chinese Pharmaceutical Association, Pakistan Pharmacists Association,

Societies in Middle East: Indonesian pharmaceutical association, Pharmaceutical Association of Malaysia (PhAMA), Malaysian Pharmaceutical Society,

The Global Drug Discovery Technologies Market is poised to grow at a CAGR of around 12.2% over the next decade to reach approximately $160 billion by 2025. Some of the prominent trends that the market is witnessing include growing identification of combinatorial chemistry technology, regulatory initiatives fostering demand for pharmacogenomics technology, proteomics in anticancer drug discovery and human protein microarray for various protein analysis.

Report Includes:

This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.

With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

In UAE

The Asia Pacific drug discovery market in 2016 was worth $6224 million. The market is expected to reach $13462 million by 2024 at a CAGR of 10.1% between 2016 and 2024. Aging population, rise in healthcare spending and increase in lifestyle oriented diseases and fatalities are some of the factors driving the drug discovery market in the Asia pacific region.

Market Insights

The drug discovery market by technology is segmented into QPCR, DNA Microarrays, Protein Microarrays, High–throughput screening, mass spectrometer, GEL Electrophoresis, Chromatograph, Protein and Nucleic Acid Isolation and other technologies.

The countries analyzed in the Asia Pacific drug discoverymarket are India, China, Japan, Korea, Australia and rest of Asia Pacific. The entry of new companies in the market and substitute products acts as a threat to the Asia pacific drug discovery market. Discovery of new drugs being delayed due to government regulations is a big restraint. Also, the drug market is shifting from branded to generics drugs which limit the growth of the drug discovery market in this region.

Pharmaceutical Associations:http://drugchemistry.pharmaceuticalconferences.com/

American Association of Pharmaceutical Scientists (AAPS)

US Food and Drug Administration (FDA)

American Society for Clinical Laboratory Science (ASCLS)

National Cancer Institute Center for Cancer Research (NCI)

American Association for Clinical Chemistry (AACC)

American Society for Pharmacology and Experimental Therapeutics (ASPET)

Association of Clinical Research Organizations (ACRO)

International Pharmaceutical Manufacturers Group (IPMG)

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	April 16-17, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View